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Abstract
Expiratory flow limitation (EFL) has been reported in pre-pubescent adolescents and
elite, adult endurance athletes; however, the occurrence of EFL in elite adolescent
endurance athletes has not been determined. Purpose: To determine incidence and
severity of EFL in elite youth male cyclists of adolescent age. We hypothesized that elite,
endurance trained youth will experience a higher prevalence and severity of EFL and
dyspnea compared to an untrained control group. Pulmonary function will be similar preto post-exercise with bronchodilation occurring in both groups. Methods: 12 elite
endurance- trained (ET) youth male cyclists (16.3 ± 1.0 years; 176.5 ± 6.2 cm; 64.2 ± 5.9
kg) and 12 recreationally active males (CON) (17.6 ± 2.2 years; 177.9 ± 7.1 cm; 74.8 ±
11.2 kg) completed an incremental test to exhaustion to determine peak oxygen
consumption (VO2peak) on a cycle ergometer. Heart rate and ventilation (VE) were
assessed throughout the exercise test. Dyspnea and ratings of perceived exertion (RPE)
were assessed at the end of each stage. Subjects performed maximal flow volume loops
(forced vital capacity (FVC), forced expiratory volume in 1-second (FEV1), FEV1/FVC,
forced expiratory flow between 25-75% of FVC (FEF25-75%) and peak expiratory flow
(PEF)) pre- and post- exercise. The occurrence and severity of EFL was quantified as the
percentage of the expiratory tidal volume that overlapped with the maximum flow
volume loop. Results: VO2peak in the ET group was 69.4±7.0 mL/kg/min and 45.7±3.9
ml/kg/min in the CON group. Peak power (390 ± 57 W vs. 273 ± 45 W) and peak VE
(158 ± 18 L/min) were higher in ET vs. CON (124.7 ± 15.3). The ET group experienced
significant EFL at VO2peak (p < 0.001), with 11/12 subjects exhibiting flow limitation. In
the CON group, 5/12 subjects exhibited EFL. There was a significant change in
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pulmonary function from pre- to post-exercise in FEV1 in both groups, with greater postexercise bronchodilation in the CON group. There was no change in FVC, FEV1/FVC,
FEF25-75% of FVC or PEF. The ET cyclists also had higher dyspnea ratings and RPE at
peak exercise (8.5 ± 1.2, p < 0.01; 18.5 ± 1.2) than CON (6.3 ± 2.6, 17.2 ± 1.6).
Conclusions: Elite youth male cyclists have a higher occurrence of and severity of EFL
at maximal exercise than recreationally active counterparts, which may limit exercise
tolerance. Considering subjects are of pubertal age, or nearing the end of puberty, the
participants may outgrow their flow limitation.

vii

1

Chapter I
Expiratory Flow Limitation in Elite Youth Cyclists
Introduction: Pulmonary System as a Limiting Factor to Exercise Tolerance
The pulmonary system does not typically limit exercise tolerance in untrained,
adult men when exercising at sea level (Dempsey et al. 1984); the arterial partial pressure
of oxygen (PO2) is maintained even during maximal exercise. Arterial PO2 closely
matches alveolar PO2 since most people do not have a dramatic desaturation at maximal
exercise; therefore, arterial PO2 is used as a proxy for alveolar PO2. There are some
situations and population-specific exceptions, however, as pulmonary limitations have
been reported in prepubescent children (Swain et al. 2010), women (Harms et al. 2006),
the elderly (Johnson et al. 1994), diseased populations [(i.e. COPD patients (Pinto-Plata
et al 2007)], and highly trained athletes (Mota et al 1999).
The partial pressure of arterial carbon dioxide (PaCO2) is regulated by increasing
ventilation rates during exercise. Specifically, an increase in tidal volume and breathing
frequency contribute to ventilation and regulation of PaCO2. Tidal volume (TV) is the
first component to increase for higher ventilatory rates, due to the increases in endinspiratory lung volume (EILV) and decreases in end-expiratory lung volume (EELV)
(Aliverti 2008). TV increases during heavy exercise until it plateau’s between 50-60% of
vital capacity. Any increase in ventilation following that plateau comes from an increase
in breathing frequency (BF) (Sheel et al. 2008). Under most conditions this increase in
ventilation can be facilitated by the pulmonary system even during maximal exercise
given the large ventilatory reserve (Aliverti 2008). However, expiratory flow limitation
(constrained ventilation) may occur when the TV approaches and intersects the
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expiratory portion of the maximal-flow volume loop (Johnson et al. 1999). The
expiratory flow limitation (EFL) and the connected hyperinflation of the lungs that occurs
to avoid the expiratory portion of the maximal flow-volume loop presents a notable
limitation in the pulmonary system, ultimately decreasing exercise tolerance by
increasing dyspnea, exercise induced arterial hypoxemia (EIAH), and RMF (Babb et al.
1991). Dynamic hyperinflation increases inspiratory muscle work and may subsequently
impair the function of inspiratory muscles (Mota 1999). The reduced dynamic lung
compliance then causes an increased work of breathing which can ultimately limit
exercise performance (McKenzie 2018). This inability to increase ventilation is
associated with exercise-induced arterial hypoxemia (EIAH) (Johnson 1992), which will
be discussed later.
EFL is caused by morphological limitations and can be exacerbated by
differences in chemoreceptor sensitivity. The chemoreceptors sense changes in O2 and
CO2 in the blood returning from limb locomotor muscles during exercise (Dempsey
2014). However, EFL also occurs due to the structural limitations of the lungs and
airways, in which they can no longer keep up with the demands of exercise. The lungs
and airways reach a limit where they cannot inflate any more than they already are,
therefore, the individual’s anatomy limits the ability of the lungs to generate higher flow
(Harms and Rosenkranz 2006).
Therefore, EFL can be explained by both the inability of the lungs and airways to
meet the ventilatory demands of exercise, as well as the lack of responsiveness in
generating higher flow rates due to reduced chemoreceptor sensitivity. As a result,
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maximal ventilation during exercise is limited by EFL (Mota 1999). When EFL occurs,
subsequent consequences such as dyspnea, RMF, EIAH may also occur.
Dyspnea
Dyspnea is defined as uncomfortable sensations while breathing (American
Thoracic Society). At maximal exercise, severe dyspnea occurs and decreases an
individual’s exercise tolerance (Weavil 2002). Weavil et al. found that when an
individual experiences high levels of EFL during exercise, dynamic hyperinflation (DH)
occurs and its implication is a feeling of breathlessness that can impair exercise tolerance.
Interestingly, when flow limitation was imposed with a Starling resistor, severe dyspnea
was experienced along with a 65% decrement in exercise performance, compared to the
control trial without flow limitation and no dyspneic sensation (Iandelli 2002). While
initial studies thought there was a strong connection between dyspnea and DH
occurrence, recent studies have shown that dyspnea and exercise intolerance is actually
associated more with EILV increases during exercise than DH (Calligaro; Guenette
2012).
Dynamic Hyperinflation and Respiratory Muscle Fatigue
When EELV increases above FRC and EILV increases near total lung capacity
(TLC), it is termed dynamic hyperinflation (Johnson et al. 1999). EFL-induced DH has
several consequences that can ultimately limit exercise tolerance. These consequences
include dyspnea, RMF, constrained ventilation and gas exchange impairments. EFL may
also cause EIAH to occur, especially in women who are more likely to experience EFL
(Walls et al. 2002). EFL can cause inadequate hyperventilation and other altered
breathing patterns that can increase the O2 cost of breathing and work of breathing (Sheel
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et al. 2008). When DH occurs, expiratory work increases, resulting in airway closure that
contributed to decreases in expiratory flow (Mota et al. 1999). DH has also been
associated with dyspnea and impaired exercise tolerance (Pellegrino et al. 1993). While
DH has been well-studied as a severe consequence of EFL, there is conflicting data
regarding whether DH is the main factor limiting exercise tolerance. For example,
Iandelli et al found that DH did not lead to impaired exercise tolerance in two of their six
subjects when EFL was externally applied. DH did not contribute to dyspnea in their
other four subjects until they achieved the highest severity of EFL in the exercise bout
leading to their conclusion that DH may be overemphasized by some researchers in its
role with exercise tolerance (Iandelli et al. 2002). In addition to EFL leading to possible
DH and dyspnea, DH can also contribute to respiratory fatigue.
During higher intensities of exercise the respiratory muscles are recruited to a
greater extent. At an intensity of greater than 80% of VO2max for ~3-5 min, diaphragmatic
fatigue may occur (Babcock et al. 1995). When diaphragmatic fatigue occurs, the
inspiratory muscle metaboreflex is initiated to vasoconstrict blood from the working limb
locomotor muscles to the diaphragm (Wetter et al. 1999). The respiratory muscles
demand more blood flow to prevent respiratory muscle fatigue. Harms et al. estimated
that 14-16% of cardiac output during maximal exercise is shunted to the respiratory
muscles (Harms, 2000). Vogiatzis et al found that the inspiratory muscle metaboreflex is
initiated between 60-80% of maximal intensity exercise and then plateaued; blood flow to
the respiratory muscles dropped off at maximal intensity exercise. They concluded that
the demands of exercise placed on the respiratory system and working skeletal muscle
could not be supported by the cardiovascular system at maximal exercise (Vogiatzis
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2009). This shift in blood can limit exercise performance due to the skeletal muscle
receiving less blood compared to the respiratory muscles (Aliverti 2008). Likewise,
Harms et al. concluded that respiratory muscles can impact exercise tolerance when the
workload is strenuous due to blood flow being redirected from the locomotor muscles to
the respiratory muscles (Harms 2000). Regarding exercise intensity, Smith et al. reported
that significant respiratory muscle fatigue occurred at 85% of VO2max, but not at 70% of
VO2max (Smith et al. 2014). This finding suggests that when athletes perform high
intensity exercise the inspiratory muscle metaboreflex is initiated, which may lead to
respiratory muscle fatigue. As mentioned previously, when EFL and DH are present, the
oxygen cost of breathing increases (Johnson et al. 1999). The additional oxygen cost of
breathing that results from DH can exacerbate exercise intolerance that was caused by
pre-existing respiratory muscle fatigue and the inspiratory muscle metaboreflex.
Special Populations
Previous research has shown that EFL tends to affect specific populations.
Prepubescent children in the United States have a high prevalence of EFL and EIAH.
Children experience EFL due to their smaller lungs that are still developing, dysynaptic
growth between the lungs and airways, and because their ventilation is higher at any
given metabolic rate (Robben et al. 2013). Children have higher chemoreceptor
sensitivity and regulate CO2 at lower levels than adults. EFL is prevalent in 70-93% of
untrained children (Emerson et al. 2015). In addition to the high prevalence of EFL
among prepubescent children, aerobic training performed by prepubescent children may
lead to greater ventilatory constraints (Nourry et al. 2005). However, the only
longitudinal study, to our knowledge, reported that once prepubescent children reach
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puberty the prevalence of EFL decreases (Emerson et al. 2015). Emerson and colleagues
state that this is most likely due to the pulmonary system further developing with
maturation (Emerson et al. 2015).
In addition to the high prevalence of EFL in children, women also have a higher
prevalence of EFL compared to men (Johnson et al. 1993). This usually occurs because
of mechanical constraints due to differences in lung size, which limit the overall function
of the pulmonary system. Also, women have less alveoli due to their smaller lungs which
decreases the total surface area for diffusion (Mead, 1980). Women also have airway
diameters that are smaller relative to their lung size compared to males leading to a lower
dysynapsis ratio, which is associated with a greater prevalence of EFL (Mead, 1980).
Women have a higher work of breathing compared to males due to a greater resistive
work in the airways (Sheel et al. 2016). All of these limitations play a role in the presence
and severity of EFL in women.
Patients with pulmonary disorders are also at risk for suffering from EFL. A study
on patients with cystic fibrosis found that EFL presence in resting tidal volume could
predict significant deterioration in lung function two years after its onset (Vilozni et al.
2016). The elderly population has also been shown to be affected by EFL due to the loss
of elastic recoil of the lungs and airways with age, along with increased dead space at rest
and during exercise (Turner et al. 1968, McKenzie, 2012).
Finally, elite adult athletes also display EFL. EFL occurs during severe intensity
exercise in many highly trained endurance athletes and other subpopulations (Aliverti
2008, Mota et al. 1999, McKenzie 2012). Highly trained endurance athletes may intersect
the boundary of their expiratory portion of the MFVL with their higher ventilation and
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become flow-limited (Aliverti 2008). While elite athletes have training adaptations to the
cardiovascular and musculoskeletal systems, they do not have training adaptations to the
pulmonary system in order to compensate for flow limitation (McKenzie 2012). The
pulmonary system can be considered “underbuilt” compared to other systems due to its
inability to adapt to training. Therefore during heavy intensity exercise, the mechanical
constraints from the lungs size can limit the maximal inflation of their lungs, which
training does not impact (Derchak 2000). Due to the increased metabolic and respiratory
demand, the higher work of breathing during heavy exercise, concomitant hyperinflation,
trained athletes often experience EFL which limits exercise tolerance (McKenzie 2012).
Significance
While EFL is present in the populations previously mentioned, the prevalence of
EFL in elite, endurance-trained adolescents has yet to be addressed. Adolescents present
a unique challenge due to their physiology. Previous studies have found that
prepubescent children tend to “outgrow” their flow limitation once puberty is reached
(Emerson 2015). Considering the prevalence of EFL is high in trained aerobic adult
athletes, elite, adolescent cyclists are an interesting population. Throughout adolescence,
the lungs and the airways may still be growing, and therefore the pulmonary system may
pose a notable limitation. Therefore, the primary purpose of this study is to determine
whether elite, endurance-trained adolescents experience EFL to a greater extent that age
and lung-size matched counterparts. A secondary purpose is to examine whether
subsequent consequences of EFL will be higher in the trained adolescents compared to
their untrained counterparts. We predict that the elite, endurance-trained adolescents will
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experience EFL and its subsequent consequences to a greater extent and at a higher
severity than their untrained peers.
In understanding the prevalence of EFL in elite adolescent cyclists compared to
untrained age-matched non-endurance trained counterparts, we will gain a better
understanding of how the pulmonary system contributes to impaired exercise tolerance in
this unique demographic.
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Chapter II
Methods
Participants
Twenty-four male subjects between the ages of 13 and 19 were recruited to
participate in the study. The study was composed of an experimental group, consisting of
elite, youth endurance-trained (ET) cyclists (n=12) and a control group (CON) of nonendurance trained, recreationally active subjects (n=12). The CON group were matched
for age, height, and absolute lung size (e.g. forced vital capacity) with the ET group. All
procedures were approved by the James Madison University Institutional Review Board
and parental consent and youth assent was obtained prior to data collection.
Experimental Design
Following height, weight, and body composition measurements (Dual-energy XRay Absorptiometry (DEXA)), subjects performed maximal flow volume loops (MFVLs)
on a SensorMedics 229 Metabolic Cart (SensorMedics Corp., Yorba Linda, Calif., USA).
This pulmonary function test is the gold standard to assess the maximum capacity of the
pulmonary system. Following the MFVL’s, participants completed a maximal exercise
test on a Velotron cycle ergometer (Velotron, Seattle, Washington, USA) until they
reached volitional fatigue. At the end of each stage during the exercise test, inspiratory
capacity (IC) maneuvers were performed. Immediately following the exercise test, the
MFVLs were repeated.
Body Composition
Height was taken to the nearest 0.1 inch using a portable stadiometer (Invicta
Height Measure; Invicta Plastics Limited, Leicester, England, UK) and weight was taken
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to the nearest 0.1 kg using a standard physician’s scale (Pelouze 4040; Health o meter,
Inc., Bridgeview, Illinois, USA). Next, the subject underwent a DEXA scan (Lunar
iDXA, General Electric Company, Boston, Massachusetts, USA). For the DEXA scan,
the subject laid supine for approximately 7-10 min until assessment of fat mass, fat free
mass, and bone mineral density was completed.
Pulmonary Function Measures
All participants were given verbal prompts during these tests and were
encouraged throughout the tests by the primary investigators. The subjects performed
MFVLs pre- and post-exercise. All tests administered adhered to the ATS/ERS guidelines
(Miller et al. 2005). Knudson (1983) reference values were used to calculate percent of
predicted lung function. To achieve an acceptable MFVL, (1) the expiratory volume in
FEV1 must be <5% of the FVC or 0.150 L, whichever is greater; (2) there must be no
cough during the first second of the expiratory portion; (3) the participant does not inhale
too early (test does not terminate early); (4) there is no hesitation during the maneuver
which may preclude an accurate measurement of FEV1 and FVC; (5) there is no leak or
obstruction in the mouthpiece and (6) the maneuver is performed correctly without an
extra breath taken. In addition, the largest MFVL was used to assess EFL presence and
severity. From the MFVL we obtained the values for forced expiratory volume in one
second (FEV1), forced vital capacity (FVC), FEV1/FVC, peak expiratory flow (PEF), and
forced expiratory flow at 25-75% of FVC (FEF25-75%).
Cardiopulmonary Exercise Testing
A graded exercise test was performed until exhaustion to determine peak oxygen
consumption (VO2peak) on a Velotron cycle ergometer after the preliminary MFVL’s.
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Ratings of perceived exertion (RPE) and dyspnea were reported during each stage of the
test. The ET group started at a self-selected wattage based on their previous training and
the CON group started at 50 watts. The workload increased for both groups by 25 every 3
min until lactate threshold was reached. Lactate threshold was determined by finger
sticks at the end of every 3-min stage using a Lactate Pro lactate analyzer (Arkray, Inc.,
Shiga, Japan). After lactate threshold was reached the subjects began the incremental
protocol for the maximal exercise test at the wattage in the stage before lactate threshold
was reached. In the incremental protocol, watts increased by 25 every min until volitional
exhaustion was reached. At the end of each one-min stage subjects were asked to rate
their dyspnea using the Dyspnea Numeric Rating Scale and RPE using Borg’s 6-20 point
scale. All subjects wore a PolarLink heart rate monitor (Bethpage, NY) throughout the
entire test, and heart rate was recorded during the last 20 s of each stage. Ventilatory and
metabolic data were recorded throughout the entire test.
Expiratory Flow and Tidal Volume Assessment
Tidal volume (VT) was assessed through a bidirectional flow sensor during the
VO2peak test. During the VO2peak test, inspiratory capacity (IC) maneuvers were performed
during the last ~20 seconds of each one-min stage of exercise. The tidal flow-volume
loops were placed inside the largest MFVL. We allowed for ~5 tidal volume loops to
appear before the subject performs the IC maneuver to ensure end-expiratory lung
volumes were consistent. The IC maneuvers were then placed within the post-exercise
MFVL to assess EFL presence and severity. The subjects were given instruction on how
to perform the IC maneuver and required to practice the maneuver at baseline before the
VO2peak test was performed. EFL was determined by the percent of intersection of the
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tidal flow-volume loop with the expiratory portion of the MFVL by 5% of greater. A
secondary investigator blinded to the initial calculations verified the percent of
intersection initially measured by the primary investigator. If the measurements differed
by >5%, a third investigator assessed the percent of the intersection and the closest two
were averaged for analysis.
Statistical Analysis
Statistical analyses for this study was performed using SPSS v.24.0. All data was
be checked for normality using the Shapiro-Wilk test to ensure parametric assumptions
were met. Data was expressed as mean ± SD in tables and mean ± SE in figures. A 2x2
mixed ANOVA (time versus group) was used to determine differences pre- and postexercise between the ET group and CON group. Significance was set to p < 0.05 for all
analyses. Bonferroni adjustments were used to account for multiple comparisons.
Pearson-product moment correlation coefficient was used to measure associations
between severity of EFL and subsequent consequences.
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Abstract
Expiratory flow limitation (EFL) has been reported in pre-pubescent adolescents and
elite, adult endurance athletes; however, the occurrence of EFL in elite adolescent
endurance athletes has not been determined. Purpose: To determine incidence and
severity of EFL in elite youth male cyclists of adolescent age. We hypothesized that elite,
endurance trained youth will experience a higher prevalence and severity of EFL and
dyspnea compared to an untrained control group. Pulmonary function will be similar preto post-exercise with bronchodilation occurring in both groups. Methods: 12 elite
endurance- trained (ET) youth male cyclists (16.3±1.0 years; 176.5±6.2 cm; 64.2±5.9 kg)
and 12 recreationally active males (CON) (17.6±2.2 years; 177.9±7.1 cm; 74.8±11.2 kg)
completed an incremental test to exhaustion to determine peak oxygen consumption
(VO2peak) on a cycle ergometer. Heart rate and ventilation (VE) were assessed throughout
the exercise test. Dyspnea and ratings of perceived exertion (RPE) were assessed at the
end of each stage. Subjects performed maximal flow volume loops (forced vital capacity
(FVC), forced expiratory volume in 1-second (FEV1), FEV1/FVC, forced expiratory flow
between 25-75% of FVC (FEF25-75%) and peak expiratory flow (PEF)) pre- and postexercise. The occurrence and severity of EFL was quantified as the percentage of the
expiratory tidal volume that overlapped with the maximum flow volume loop. Results:
VO2peak in the ET group was 69.4±7.0 mL/kg/min and 45.7±3.9 ml/kg/min in the CON
group. Peak power (390 ± 57 W vs. 273 ± 45 W) and peak VE (158 ± 18 L/min) we
higher in ET vs. CON (124.7 ± 15.3). The ET group experienced significant EFL at
VO2peak (p < 0.001), with 11/12 subjects exhibiting flow limitation. In the CON group,
5/12 subjects exhibited EFL. There was a significant change in pulmonary function from
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pre- to post-exercise in FEV1 in both groups, with greater post-exercise bronchodilation
in the CON group. There was no change in FVC, FEV1/FVC, FEF25-75% of FVC or PEF.
The ET cyclists also had higher dyspnea ratings and RPE at peak exercise (8.5 ± 1.2, p <
0.01; 18.5 ± 1.2) than CON (6.3 ± 2.6, 17.2 ± 1.6). Conclusions: Elite youth male
cyclists have a higher occurrence of and severity of EFL at maximal exercise than
recreationally active counterparts, which may limit exercise tolerance. Considering
subjects are of pubertal age, or nearing the end of puberty, the participants may outgrow
their flow limitation.

The pulmonary system does not usually limit exercise tolerance in untrained,
adult men when exercising at sea level (Dempsey et al. 1984). Under most conditions, the
increase in ventilation can be maintained by the pulmonary system even during maximal
exercise since there is large ventilatory reserve that can be utilized (Aliverti 2008).
However, in specific populations, the pulmonary system may be a limitation during
prolonged exercise and maximal exercise. Specifically, a condition called expiratory flow
limitation (EFL; constrained ventilation) may occur in prepubescent children, women,
elite adult endurance athletes, pulmonary disease patients, and the elderly, and it is
characterized by a tidal volume (VT) that approaches and intersects the expiratory portion
of the maximal-flow volume loop (Johnson et al. 1999). The EFL and the associated
hyperinflation of the lungs that occurs to avoid the expiratory portion of the maximal
flow-volume loop presents a notable limitation in the pulmonary system, ultimately
decreasing exercise tolerance (Babb et al. 1991).
In heavy endurance exercise, ventilatory requirements are extremely high to meet
the metabolic demands of exercise. While this increase in metabolic demand is placed on
the lungs, the total capacity of the lungs and chest wall to generate flow and increase
volume does not adapt with exercise training, and therefore the total ventilatory capacity
is not different between trained and untrained individuals. In addition, several studies
have suggested that highly trained individuals have altered chemoreceptor sensitivity and
therefore lack and adequate hyperventilatory response to maximal exercise (Johnson
1992). Therefore, the lungs and airways reach a limit where they cannot inflate beyond
their existing capacity, and this structural limitation precludes individuals from
generating higher flow (Harms et al. 2006). With this morphological limitation, maximal
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ventilation during exercise is limited by EFL (Mota et al. 1999). In addition, the
regulation of lung volumes [end-inspiratory lung volume (EILV) and end-expiratory lung
volume (EELV)] also affects ventilatory constraint during exercise. When EELV
increases above functional residual capacity (FRC) and EILV increases near total lung
capacity (TLC), it is termed dynamic hyperinflation (DH) (Johnson et al. 1999). The
presence of EFL and subsequent DH can limit exercise tolerance by increasing dyspneic
sensations (Weavil et al. 2015), respiratory muscle fatigue (Dempsey et al. 2008) and gas
exchange impairments (Weavil et al. 2015).
While EFL has been reported in specific populations, such as women (McClaran
et al. 1998), older adults (Smith et al. 2017), pre-pubescent children (Swain et al. 2010,
Smith et al. 2015), and endurance trained athletes (Johnson et al. 1992), the prevalence of
EFL in elite, endurance-trained youth cyclists, has yet to be studied. Previous studies
have found that prepubescent, recreationally active youth tend to “outgrow” their flow
limitation once puberty is reached (Emerson et al. 2015). Still, while elite endurance
athletes have training adaptations to the cardiovascular and musculoskeletal systems,
their pulmonary system does not appear to adapt in a manner that can compensate for
flow limitation (McKenzie, 2012). Considering the prevalence of EFL is high in
aerobically trained adult athletes, elite youth cyclists of pubertal age are an interesting
population to be studied. Moreover, given that the lungs and airways of youth endurance
athletes may not have reached full development, yet the ventilatory and metabolic
requirements are extremely high in heavy endurance exercise, the pulmonary system may
pose a notable limitation to meet the demands of heavy exercise. Therefore, the primary
purpose of this study was to determine the presence and severity of EFL in elite,
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endurance-trained (ET) youth cyclists of pubertal age compared to their age, height, and
lung-size matched counterparts. The secondary purpose was to examine whether
pulmonary function and dyspnea will be different during exercise in the ET group
compared to an untrained control (CON) group. We predict that the ET youth cyclists
will experience a higher prevalence and greater severity of EFL and dyspnea compared to
CON group, however pulmonary function will be similar from pre- to post-exercise with
bronchodilation occurring in both the ET and CON groups.
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Methods
Participants
Twenty-four male subjects between the ages of 13 and 19 were recruited to
participate in the study. The study was composed of an experimental group, consisting of
elite, endurance trained (ET) youth cyclists (n=12), and a CON group of non-endurance
trained recreational cyclists (n=12). The CON group were matched for age, height, and
absolute lung size (e.g. forced vital capacity) with the ET group. All procedures were
approved by the James Madison University Institutional Review Board and parental
consent and youth assent was obtained prior to data collection.
Experimental Design
Following height, weight, and body composition measurements [Dual-energy XRay Absorptiometry (DEXA)], subjects performed maximal flow volume loops (MFVL)
on a SensorMedics 229 Metabolic Cart (SensorMedics Corp., Yorba Linda, Calif., USA).
This pulmonary test is the gold standard to assess the maximum capacity of the
pulmonary system. Following the MFVL’s, participants completed a maximal exercise
test on a Velotron cycle ergometer (Velotron, Seattle, Washington, USA) until they
reached volitional fatigue (described below). At the end of each stage during the exercise
test, inspiratory capacity (IC) maneuvers were performed. Immediately following
volitional fatigue, the MFVLs were repeated.
Anthropometrics
Height was taken to the nearest 0.1 inch using a portable stadiometer (Invicta
Height Measure; Invicta Plastics Limited, Leicester, England, UK) and weight was taken
to the nearest 0.1 kg using a standard physician’s scale (Pelouze 4040; Health o meter,
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Inc., Bridgeview, Illinois, USA). Next, the subject underwent a DEXA scan (Lunar
iDXA, General Electric Company, Boston, Massachusetts, USA). For the DEXA scan,
the subject laid supine for approximately 7-10 min until assessment of fat mass, fat free
mass, and bone mineral density was completed.
Pulmonary Function Measures
All participants were given verbal prompts during this test and were encouraged
throughout the test by the primary investigators. The subjects performed MFVLs pre- and
immediately post-exercise. All of the pulmonary function tests that were administered
adhered to the ATS/ERS guidelines (Miller 2005). Knudson (1983) reference values were
used to calculate percent of predicted lung function. To achieve an acceptable maximum
flow volume loop (MFVL): (1) the expiratory volume in FEV1 must be <5% of the FVC
or 0.150 L, whichever is greater; (2) there must be no cough during the first second of the
expiratory portion; (3) the participant does not inhale too early (test does not terminate
early); (4) there is no hesitation during the maneuver which may preclude an accurate
measurement of FEV1 and FVC; (5) there is no leak or obstruction in the mouthpiece and
(6) the maneuver is performed correctly without an extra breath taken. In addition, the
largest MFVL was used to assess EFL presence and severity. From the MFVL we
obtained the values for forced expiratory volume in one second (FEV1), forced vital
capacity (FVC), FEV1/FVC, peak expiratory flow (PEF), and forced expiratory flow at
25-75% of FVC (FEF25-75%).
Cardiopulmonary Exercise Testing
A graded exercise test was performed until exhaustion to determine VO2peak on a
Velotron cycle ergometer after the MFVLs. Ratings of perceived exertion (RPE) and
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dyspnea were reported during each stage of the test. The ET group started at a selfselected wattage based on their previous training and the CON group started at 50 W. The
workload increased for both groups by 25 W every 3-min until lactate threshold was
reached. Lactate threshold was determined by finger sticks at the end of every 3-min
stage using a Lactate Pro lactate analyzer (Arkray, Inc., Shiga, Japan). After lactate
threshold was reached the subjects began the incremental protocol for the maximal
exercise test at the wattage in the stage before lactate threshold was reached. In the
incremental protocol, workload increased by 25 W every minute until volitional
exhaustion was reached. At the end of each one-min stage subjects were asked to rate
their dyspnea using the Dyspnea Numeric Rating Scale and RPE using Borg’s 6-20 point
scale. All subjects wore a PolarLink heart rate monitor (Bethpage, NY) throughout the
entire test, and heart rate was recorded during the last 20 seconds of each stage.
Ventilatory and metabolic data were recorded throughout the entire test.
Expiratory Flow and Tidal Volume Assessment
Tidal volume (VT) was assessed through a bidirectional flow sensor during the
VO2peak test. Prior to the VO2peak test, subjects were given instruction on how to perform
the inspiratory capacity (IC) maneuver and were required to practice the maneuver at
baseline. During the VO2peak test, IC maneuvers were performed during the last ~20
seconds of each one-min stage of exercise. We allowed for ~5 tidal volume loops to
appear before the subject performed the IC maneuver to ensure end-expiratory lung
volumes were consistent. The IC maneuvers were then superimposed within the postexercise MFLV to assess EFL presence and severity. EFL was determined by the percent
of intersection of the tidal flow-volume loop with the expiratory portion of the MFVL by

7

5% or greater. A secondary investigator blinded to the initial calculations verified the
percent of intersection initially measured by the primary investigator. If the
measurements differed by >5%, a third investigator assessed the percent of the
intersection and the closest two were averaged for analysis. To assess EFL severity at
specific exercise intensities, the VO2 value that was closest to the correct intensity for
each subject at 20%, 40%, 60%, 80% or 100% of VO2peak, was used for the analysis.
Assessing EFL severity over a relative range of values dependent on individual subjects
responses during exercise has previously been used in the literature to measure EFL
severity and operative lung volumes as a % of VO2peak (Emerson et al. 2014, Guenette
et al. 2010), or EFL severity and operative lung volumes over various ventilations (Smith
et al 2017).
Statistical Analysis
Statistical analyses for this study were performed using SPSS v.24.0. All data was
checked for normality using the Shapiro-Wilk test to ensure parametric assumptions were
met. Data were expressed as mean ± SD in tables and mean ± SE in figures. A 2x2 mixed
ANOVA (time versus group) was used to determine differences pre- and post-exercise
between the ET group and CON group for EFL severity and changes in operating lung
volumes. Significance was be set to p < 0.05 for all analyses. Bonferroni adjustments
were used to account for multiple comparisons. Pearson-product moment correlation
coefficient were used to measure associations between severity of EFL, ventilation and
subsequent consequences (dyspnea and RPE).
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Results
Subject Characteristics
Subject characteristics are shown in Table 1. The ET group were matched to the
CON group by age (p = 0.085), height (p = 0.616) and FVC (p = 0.225). There was a
significant difference between the two groups for weight (p = 0.009) and body fat
percentage (p = 0.006). Maximal exercise and ventilatory values from the VO2peak test are
shown in Table 2. At VO2peak, the CON group had significantly lower absolute VO2,
relative VO2, peak power, peak VE and VCO2. Subjects in the CON group had significantly
lower dyspneic ratings (p = 0.014) and RPE (p = 0.035) at peak exercise, but significantly
higher RER values (p = 0.001).
Expiratory Flow Limitation
EFL at 20, 40, 60, 80, and 100% of VO2peak is shown in Figure 1. Both ET and CON
had significantly increased EFL severity from baseline to peak exercise (p < 0.001),
however the ET group experienced a higher severity of EFL from baseline to peak exercise
(p = 0.001). Specifically, 11/12 subjects in the ET group were flow-limited and 5/12 in the
CON group were flow limited, with 75.0 ± 32.9 % of EFL severity in the ET and 29.7 ±
40.4% of EFL severity in the CON group.
Pulmonary Function
Pulmonary function measurements are shown in Table 3. There were no significant
differences in absolute lung volumes or flow rates between the ET and CON at baseline.
From pre- to post-exercise, both groups significantly increased FEV1 (p = 0.002),
FEV1/FVC (p < 0.001), FEF25%-75% of FVC (p < 0.001), however there was no significant
differences from pre- to post-exercise in FVC (p = 0.096) or PEF (p = 0.984). In addition,
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there was a significant interaction between the ET and CON groups over time in FEV1 (p
= 0.025), however not in FVC, FEV1/FVC, FEF25%-75% of FVC, or PEF.
Operating Lung Volumes
Operating lung volumes (EILV and EELV) in CON and ET subjects are displayed in
Figure 2 as a percentage of FVC. EELV decreased from baseline (36.5 ± 8.1% of FVC), at
20% (37.5 ± 9.7% of FVC) at 40% (34.9 ± 8.9% of FVC), 60% (34.8 ± 7.2% of FVC),
80% (34.7 ± 6.6% of FVC) and 100% of VO2peak (34.4 ± 7.8% of FVC), however changes
were not significant as a main effect of time (p = 0.219) or between ET and CON across
time (p = 0.206). There were significant increases in EILV across time points (p < 0.001)
from baseline (59.8 ± 10.3% of FVC) to 100% of VO2peak (87.9 ± 7.9% of FVC), but no
difference in EILV between the ET and CON groups across time (p = 0.742).
Ventilatory Responses to Exercise, EFL and Subsequent Outcomes
The present study found no associations between EFL and ventilation, dyspnea ratings,
or RPE at VO2peak (Figures 3A-C). In addition, there was no association between the change
in FEV1 from pre- to post-exercise (r = -0.025, p = 0.909), or EFL with body fat percentage
(r = -0.217, p= 0.303). Also, there was a significant increase in VE/VCO2 across time,
however there was not a significant interaction between the ET and CON groups across
time (p = 0.895). There was a significant increase in VE/VO2 throughout the exercise
protocol (p < 0.001), however there was not a significant interaction between the ET and
CON groups across time (p = 0.314).
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Discussion
Major Findings
This study investigated the prevalence and severity of EFL in elite, ET youth
cyclists, in comparison to recreationally active untrained CON subjects matched by age,
height, and lung-size (FVC). Our major finding was that the ET group had a greater EFL
prevalence and severity than the CON group. In addition, post-exercise bronchodilation
differed between the CON and ET groups, though it did not appear to be associated with
EFL. Operating lung volumes were not different between the ET and CON groups,
however EILV increased during exercise in both groups. Finally, though not associated
with EFL severity, dyspnea ratings were higher in the ET group at peak exercise.
EFL Presence and Severity in Trained vs Untrained Subjects
There was a greater prevalence of EFL in the ET group, and a greater severity of
EFL at peak exercise in the ET group compared to the CON group. While this is in
agreement with the previous literature showing most (> 90%) endurance trained adult
males have EFL (Johnson et al.), Emerson et al. conducted a longitudinal study that
reported that untrained, adolescent subjects of similar age (15.3 ± 0.5 y) to the subjects in
the present study (16.9 ± 1.8 y) tend to outgrow their flow-limitation. Specifically,
Emerson et al. reported that 10 of 11 pre-pubertal boys exhibited EFL at VO2max. Five
years later, only 5 of these 11 subjects (measured post-pubertal) exhibited EFL at VO2max.
In the present study, 11 out of 12 elite, ET cyclists exhibited EFL. These findings
are consistent with several studies in endurance trained adult athletes, however the
prevalence of EFL in endurance trained adult athletes is not consistent in the existing
literature. Specifically, a study performed by Mota and colleagues showed that only 1 out
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of 10 competitive cyclists exhibited EFL at peak exercise. However, subjects in their
study were 21 ± 5 years of age, and likely had reached full maturation. Therefore,
discrepancies between the present study and Mota et al.’s work may be explained by
maturation stage of the subjects. Yet differences may also exist due to the study
methodology utilized for the assessment of EFL. Specifically, Mota et al. assessed
endurance trained young adults by applying negative expiratory pressure at the mouth,
where we used the overlap method that has been validated in many studies (Johnson et al.
1999, Smith et al. 2014, Chenoweth et al. 2015, Smith 2017). While both methods are
acceptable and commonly used, not accounting for thoracic gas compression in the
present study may overestimate the severity of EFL experienced (discussed in the
limitations section) (Guenette et al. 2010). While differences exist in the study
methodology, there are similarities in VO2max scores between subjects in both studies (72
± 6 mL/kg/min in Mota and 69 ± 7 mL/kg/min in the present study) as well as similar
ventilation at VO2max (147 ± 20 L/min and 157.5 ± 18.1 L/min, respectively). Taken
together, these findings suggest that differences in reported EFL presence are due to
either methodological differences and/or differences in lung size due to maturation stage,
since age was different but not fitness level of the endurance athletes.
While Mota and colleagues suggest flow limitation is not prevalent in endurance
trained athletes, several research studies report that EFL prevalence and severity is
moderate-high in this unique population (Nourry et al. 2005, Johnson et al. 1992).
Johnson and colleagues have found that 4/8 adult endurance runners exhibited EFL at
peak exercise, yet another study reports most endurance trained cyclists exhibit EFL at
peak exercise (> 80%) (Tecklenburg-Lund et al 2011). This difference in EFL presence
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could be partly due to the impact cycling posture has on operating lung-volumes in the
riding position, which has recently been reported by Duke et al. (2014). However, the
impact of different riding positions on EFL has yet to be determined in youth. While the
literature reporting EFL presence is conflicting, it may be possible for endurance athletes
to outgrow their flow limitation once they have reached full maturation. However, it is
clear that not all individuals outgrow their flow limitation based on the prevalence of this
phenomenon in highly fit adult athletes. Without a longitudinal study that follows the
same cohort of endurance athletes from puberty into adulthood, we cannot determine
whether these specific athletes will outgrow their flow limitation.
Interestingly, the only time point at which EFL severity was different between the
CON and ET group was at peak exercise, which is supported by the existing literature
where EFL has been reported in endurance trained adults. Specifically, Johnson and
colleagues have shown that EFL does not appear until peak exercise, even when EFL was
impending at moderate to heavy intensities. With impending EFL, DH occurs, and
subjects breathe at a higher lung volume to meet the metabolic demands of heavy
exercise. Johnson and colleagues reported that participants hyperventilated when
breathing at higher lung volumes, exacerbating the mechanical constraint. Endurance
trained athletes have an increased ventilatory requirement during exercise than nontrained counterparts due to higher achievable workloads, which leads to mechanical
constraints at peak exercise (Johnson et al. 1992). In the present study, we matched the
ET and CON group for height and FVC, and EFL was still present in both groups, but
with a much greater percentage and severity at peak exercise in the ET group. Therefore,
since FVC was matched in the ET and CON group, but absolute ventilation achieved was
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higher in the ET compared to the CON group, there is likely still an anatomical limitation
present during pubertal age or immediately post-puberty, which subjects may outgrow
into adulthood.
The present study found that there was no association between peak ventilation,
dyspnea or RPE at peak exercise and severity of EFL. These findings are in agreement
with that of Pianosi and colleagues (2019) who reported that youth and adolescent
subjects exhibited EFL and dyspnea; however the degree of dyspnea was not associated
with EFL or ventilation. Specifically, half of the subjects in their study cited difficulty
breathing as their reason for stopping the exercise test. Several subjects that did not
exhibit EFL still had dyspneic sensations that they cited as their primary reason for
stopping the exercise test. In addition, dyspneic sensations have been reported to be
higher when EFL is present, which may cause exercise intolerance (Stickland et al.
2012). Therefore, it is not surprising that the subjects in the ET group had higher
dyspneic sensations compared to the CON group, but it was surprising that there were no
associations between dyspnea and severity of EFL in the ET group.
Pulmonary Function
The only pulmonary function outcome measurements that were different from
pre- to post-exercise were FEF25-75%, of FVC, FEV1/FVC, and FEV1. Interestingly, FEV1
was the only variable from the PFTs to have a significant difference among the groups
across time, showing there was a difference in bronchodilation from pre- to post-exercise
in the CON group when compared to the ET group. FEV1 typically increases postexercise due to an increase in cartilage stiffness with increased ventilation rates during
exercise. The difference in FEV1 between the ET and CON groups over time is

14

interesting because typically with higher ventilation rates, there is greater post-exercise
bronchodilation. While bronchodilation occurs in normal, healthy airways, exerciseinduced bronchoconstriction (EIB) occurs in approximately 10-50% of elite athletes
depending on their sport and is especially common in athletes those who compete in
national and international endurance events (Mohammadizadeh et al. 2013, Helenius et
al. 1998). EIB is the narrowing of the large airways post-exercise and is caused by water
loss from the airway membranes, which dries out the airways. Prolonged hyperventilation
while training in conditions that expose endurance athletes to allergens and bronchial
irritants during the exercise bout may increase EIB prevalence in an elite, endurance
trained population (Helenius et al. 1998, 2000). Hyperventilation increases the pressure
exerted on the airways and along with the lack of moisture, may cause damage to the
airway’s epithelium. This damage then triggers the injury-repair process which can lead
to bronchial hyper-responsiveness, typically seen 5-15 min post-exercise, yet is resolved
within an hour post-exercise (Kippelen et al. 2012, Rundell et al. 2002, McFadden et al.
1986). While EIB is typically reported in the 5-15 min post-exercise time period,
bronchoconstriction has also been seen during exercise, which may impair exercise
tolerance (Beck et al. 1994). In the present study, we only assessed pulmonary function
pre- and post-exercise, and therefore it is difficult to determine whether the ET subjects
were starting to exhibit or would have potentially had EIB. However, it is possible the
individuals with the least amount of bronchodilation post-exercise could have had
excessive drying of the airways, which is a cause of EIB, and this may have impacted
exercise tolerance or post-exercise bronchodilation.
Operating Lung Volumes and Ventilation

15

An interesting finding in the present study was that there were no differences
between groups in EELV across time-points, however there were increases in EILV,
which is consistent with the previous literature. EILV increased steadily throughout the
exercise test, similar to previous findings (Mota et al. 1999). In the present study, subjects
that had flow limitation also showed DH, which explains the increase in EILV.
Interestingly, the subjects in the CON group likely showed DH to avoid flow limitation,
but may have reached volitional fatigue before having constrained ventilation due to
EFL. Therefore, it is possible that with impending EFL, subject’s lungs began to
hyperinflate, but ventilation did not need to reach high enough rates to be limited by their
morphology. This may also explain why ventilation was not associated with EFL severity
in flow-limited subjects (with CON and ET subjects combined). Whether DH occurs with
impending EFL or when EFL first occurs still remains to be elucidated. The present
findings for EELV are not in agreement with the majority of the current literature. Mota
et al reported that EELV decreased during moderate intensity exercise by 13%, but then
increased as they approached peak exercise due to DH, however their subjects exhibited
EFL when DH occurred. Since the ET showed a high prevalence of EFL in the present
study, the degree of DH was likely so high that significant changes in EELV were not
present, even with much greater tidal volumes. In addition, the CON group experienced
DH, but presumably did not achieve high enough workloads and ventilation rates to be
flow-limited.
Limitations
The primary limitation of this project is that we did not account for thoracic gas
compression, which may have led to an overestimation of EFL in our subjects. However,
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previous studies using independent measurements of transpulmonary pressures during
expiration report a close agreement with the severity of EFL between methodologies
(Johnson et al. 1991). Unfortunately, we were not able to obtain maturation status via
Tanner Stages, and therefore were only able to match for age, FVC, and height. Due to
their ages, it is likely that they are of nearing the end of puberty but are still considered
youth. Also, this study also did not include female endurance athletes. Due to females
having a higher prevalence of EFL and varying dysynapsis ratios (airway size relative to
lung size), we cannot generalize our findings to the entire population of elite youth
cyclists of both sexes. Finally, future studies should assess pulmonary function pre- and
post-exercise, as well as 5, 10, and 30 min post-exercise to better understand airway
function relative to ventilation rates and EFL severity.
Future Directions
Since the prevalence of EFL differs between the sexes, assessment of the
prevalence and severity of EFL in an elite endurance trained female population should be
conducted. Also, it would be interesting to elucidate the prevalence and severity of EIB in
elite endurance youth of both sexes since the current data in adolescents is scarce.
Perhaps the most interesting area for future research is to assess whether the ET cyclists
in the current study outgrow their flow limitation, or remain flow limited into adulthood,
which would provide important longitudinal data on the pulmonary system limitations to
exercise throughout the lifespan.
Conclusions
This is the first study, to our knowledge, to investigate and identify a high
prevalence of EFL in ET youth athletes of pubertal age or nearing the end of puberty.
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Also, ET athletes have significantly greater EFL severity compared to recreationally
active, untrained CON subjects matched for age, height and FVC. Whether or not these
specific athletes will outgrow their flow limitation into adulthood is an interesting area
for future research to better understand the development of the pulmonary system, as well
as to understand possible limitations to exercise performance throughout the lifespan.
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Figure Legends
Figure 1. Severity of EFL during exercise for the ET and CON groups. Severity of EFL
across VO2 values (x-error bars included to represent ranges) for the ET (open circles)
and CON (closed circles) groups. There was significantly greater EFL severity in both
groups from baseline to VO2peak (p<0.001). Compared to the CON group, the ET group
experienced an even greater severity of EFL at peak exercise (p=0.004). *Significantly
different from CON group.
Figure 2. Operating lung volumes during exercise for ET and CON groups. Operating
lung volumes across VO2 values (x-error bars included to represent ranges) for the ET
(open circles) and CON (closed circles) groups. EELV did not change across time or
between groups (p>0.05). EILV increased in both group (p<0.05), however was not
different between the ET and CON groups. *Significantly different in ET and CON from
baseline to VO2peak (p<0.05).
Figure 3a. Peak Ve as EFL severity in flow-limited subjects. There were 11 flow-limited
subjects in the ET group and 5 subjects in the CON group).
Figure 3b. Dyspnea and EFL severity in flow-limited subjects.
Figure 3c. RPE and EFL severity in flow-limited subjects.
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Values are mean ± SD.
*Significantly different between ET and CON (p < 0.05)
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Values are mean ± SD. VO2, Oxygen consumption; VCO2, carbon dioxide
produced; VE, ventilation; RPE, Rating of Perceived Exertion; RER,
respiratory exchange ratio; VE/CO2, ventilatory equivalent for VCO2;
VE/VO2, ventilatory equivalent for VO2; EELV, end expiratory lung
volume; EILV, end inspiratory lung volume; EFL, expiratory flow
limitation.
*Significantly different between ET and CON (p < 0.05)
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Values are mean ± SD. PEF, peak expiratory flow; FVC, forced vital
capacity; FEV1, forced expiratory volume in 1 second; FEV1/FVC, forced
expiratory volume in 1 second/forced vital capacity; FEF25-75%, forced
expiratory flow at 25-75% of pulmonary volume.
a
Significantly different between ET and CON from pre- to postexercise (p < 0.05).
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*

Figure 1. Severity of EFL during exercise for the ET and CON groups.
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Figure 2. Operating lung volumes during exercise for ET and CON groups.
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Figure 3a. Peak VE as EFL severity in flow-limited subjects. There were 11 flow-limited
subjects in the ET group and 5 subjects in the CON group.

r=0.07, p=0.81

Figure 3b. Dyspnea and EFL severity in flow-limited subjects.

r=-0.26, p=0.34

Figure 3c. RPE and EFL severity in flow-limited subjects.

r=-0.21, p=0.43
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Respiratory responses to exercise and prevalence of expiratory flow
limitation in adolescent endurance athletes and untrained controls.
Parent/Guardian Informed Consent
IRB #18-0548
Identification of Investigators & Purpose of Study
Your child is being asked to participate in a research study conducted by Dr. Stephanie
Kurti, Dr. Mike Saunders, Dr. Nick Luden, and Katherine Smith from James Madison
University (JMU). The purpose of this study is to examine respiratory responses to
exercise in endurance trained adolescent cyclists and recreationally active, untrained
adolescent subjects.
Research Procedures
Should you decide to allow your child to participate in this research study, you will be
asked to sign this consent form once all your questions have been answered to your
satisfaction.
By participating in this study, the researchers will ask your child to perform (1) a body
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing
protocol and (4) a series of questionnaires. Each step is outlined in detail below.
Additionally, to participate in the research, your child must be healthy and not diagnosed
with any cardiovascular (i.e. heart murmur, aortic stenosis, unstable angina, active
endocarditis, acute myocarditis, hypertension), pulmonary (i.e. obstructive or restrictive
diseases), or metabolic diseases (i.e., type 1 and type 2 diabetes, insulin resistance,
hyper/hypothyroidism); or any other diseases in these categories that are included in the
American College of Sports Medicine guidelines.
1) Body composition assessment:
When your child first arrives to the laboratory, height, weight and body composition will
be assessed. A DEXA analysis will be performed for body composition assessment. For
the DEXA procedure, your child will be asked to lie down on their back and remain still
for approximately 5-10 minutes until the scan is completed. All body composition
assessment will be performed according to the American College of Sports Medicine
guidelines.
2) Pulmonary Function Testing:
Following body composition assessment, your child will be asked to undergo standard
pulmonary function testing according to the American Thoracic Society guidelines.
Duration for the tests are dependent on the effort of your child and how quickly they
learn to adequately perform the tests. Therefore, the duration of pulmonary function
testing will be approximately 20-30 minutes total. These tests include nitrogen washout
to assess total lung capacity (TLC). For this test, your child will simply breathe into a
mouthpiece attached to the metabolic cart for ~7 minutes with a nose-clip on. After this,
your child will perform the maximum flow-volume loop, where your child will be asked
to perform a maximal inhale followed by a exhale where they will be asked to completely
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empty their lungs and hold it for 6 seconds, followed by another maximum inhale. Next,
your child will be asked to perform a maximal exhale, maximal inhale and then be asked
to hold their breath for approximately 5 seconds, and then asked to perform another
exhale. This test measures the diffusion capacity of the lung. The next respiratory test
will be a test in which your child will maximally exhale and inhale against a closed valve
to measure maximum inspiratory and expiratory pressures. Every pulmonary function test
is non-invasive and only involves various breathing maneuvers.
3) Exercise Testing:
Your child will then perform an incremental exercise test until volitional fatigue. The
exercise testing protocol will take approximately 15-20 minutes from start to complete.
This test simply requires your child to start pedaling a bike at 50 watts (if recreationally
active) or self-selected watts (if endurance trained in cycling) and increase the watts by
25 every 3 minutes until lactate threshold is reached. For lactate threshold, your child will
undergo a finger stick at the end of every three-minute stages (typically three in total).
When a specific blood lactate is reached, your child will undergo 1 minute stages
increasing 25 watts/minute until volitional fatigue, or until they cannot turn the pedals
anymore and choose to stop the test. Before and after the exercise test your child will
complete several of the standard pulmonary function assessments described above.
Time Required
Participation in this study will require one session that will be approximately two hours in
duration, in which all testing can be completed.
Risks
The investigators do not perceive more than minimal risks from your child’s involvement
in this study (that is, no risks beyond the risks associated with everyday life). Any
potential risks associated with the testing itself were outlined in the consent forms for
performance testing.
Additionally, the DEXA scan entails a low dose of radiation equivalent to approximately
one transatlantic flight (0.015 mSv= milliseievert). While there is no validated
questionnaire to define extensive exposure, radiation exposure is cumulative (200 DEXA
scans is equal to the cumulative exposure of living at sea level for a year (3 mSv)).
DEXA scans carry minimal X-ray exposure. To minimize exposure, the DEXA scan will
only be performed once.
Benefits
1) The exercise test to volitional fatigue is the best indicator of overall health. This is an
important and useful value for you and your child to be aware of. Additionally, we will
let you know how he/she compared to individuals of the same age.
2) The data obtained from this project will be used to better understand the responses of
adolescent athletes to high-level endurance training. Therefore, athletes may be able to
use the data from this study to make well-informed decisions regarding your child’s
future training.
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3) This research study will give physiologists, clinicians and sports practitioners more
information about lung function and limitations to exercise tolerance, which may lead to
improved advice for youth athletes.
It should be noted that while these are foreseeable benefits of your child’s participation in
the study, they are not guaranteed.
Payment for participation
There is no payment for taking part in this study.
Confidentiality
The results of this research will be presented in classroom presentations, conferences and
research journals. Your child will be identified in the research records by a code name or
number. The researchers retain the right to use and publish non-identifiable data. When
the results of this research are published or discussed in conferences, no information will
be included that would reveal your child’s identity. All data will be stored in a secure
location accessible only to the researchers. All information that matches up individual
respondents with their code number will be stored in a secure location separate from their
data.
There is one exception to confidentiality we need to make you aware of. In certain
research studies, it is our ethical responsibility to report situations of child abuse, child
neglect, or any life-threatening situation to appropriate authorities. However, we are not
seeking this type of information in our study nor will you be asked questions about these
issues.
Participation & Withdrawal
Your child’s participation is entirely voluntary. He/she is free to choose not to
participate. Should you and your child choose to participate, he/she can withdraw at any
time without consequences of any kind.
Questions about the Study
If you have questions or concerns during the time of your child’s participation in this
study, or after its completion or you would like to receive a copy of the final aggregate
results of this study, please contact Dr. Stephanie Kurti at kurtisp@jmu.edu and (630)
205- 6363, Dr. Mike Saunders at saundemj@jmu.edu and (540) 568-8121, Dr. Nicholas
Luden at ludennd@jmu.edu and (540) 568-4069.
For any questions about Your Rights as a Research Subject, please contact Dr. David
Cockley:
Chair, Institutional Review Board, James Madison University, (540) 568-2834,
cocklede@jmu.edu
Giving of Consent
I have read this consent form and I understand what is being requested of my child as a
participant in this study. I freely consent for my child to participate. I have been given
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satisfactory answers to my questions. The investigator provided me with a copy of this
form. I certify that I am at least 18 years of age.
______________________________________
Name of Child (Signed)

______________
Date

______________________________________
Name of Parent/Guardian (Printed)

______________
Date

______________________________________
Name of Parent/Guardian (Signed)

______________
Date

______________________________________
Name of Researcher (Signed)

______________
Date
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YOUTH ASSENT FORM (Ages 13-17)
IRB #18-0548
Respiratory responses to exercise and prevalence of expiratory flow
limitation in adolescent endurance athletes and untrained controls.
We are inviting you to participate in this study because you are either a recreationally
active adolescent individual, or currently are an endurance trained adolescent cyclist. We
are interested in studying how your lung and airways responds to exercise, and may
possibly limit your exercise ability.
By participating in this study, the researchers will ask you to perform (1) a body
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing
protocol and (4) a series of questionnaires. Each step is outlined in detail below.
Additionally, you are not allowed to participate in this research study if you have been
diagnosed with any cardiovascular, respiratory, or metabolic diseases. We will ensure
with your parents that you have not been diagnosed with any of these types of diseases.
1) Body composition assessment:
When you first arrive to the laboratory, height, weight and body composition will be
assessed. An analysis will be formed for body composition assessment (fat mass and lean
muscle mass). To minimize exposure, the scan will only be performed once. For the
DEXA procedure, you will be asked to lie down on your back and remain still for
approximately 5-10 minutes until the scan is completed. All body composition
assessment will be performed according to the American College of Sports Medicine
guidelines.
2) Pulmonary Function Assessment:
Following body composition assessment, you will be asked to undergo standard
pulmonary function testing (to test how your lungs function) according to the American
Thoracic Society guidelines. Tests are dependent on your effort and how quickly you
learn to adequately perform the tests. Therefore, the duration of pulmonary function
testing will be approximately 20-30 minutes total. These tests include a test where we can
first measure the total capacity of your lungs. For this test, you will simply breathe into a
mouthpiece attached to the metabolic cart for ~7 minutes with a nose-clip on. After this,
you will perform a test where you will be asked to perform a maximal inhale followed by
a exhale where you will be asked to completely empty your lungs and hold it for 6
seconds, followed by another maximum inhale. Next, you will be asked to perform a
maximal exhale, maximal inhale and then be asked to hold your breath for approximately
5 seconds, and then asked to perform another exhale. This test measures the diffusion
capacity of your lung. The next respiratory test will be a test in which you will maximally
exhale and inhale against a closed valve to measure maximum inspiratory and expiratory
pressures. Every pulmonary function test is non-invasive and only involves various
breathing maneuvers.
3) Exercise Testing:
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You will then perform an incremental exercise test until volitional fatigue. The test
duration is only about 15-20 minutes from start to finish. This test simply requires you to
start pedaling a bike at 50 watts (if recreationally active) or self-selected watts (if
endurance trained in cycling) and increase the watts by 25 every 3 minutes until lactate
threshold is reached. For lactate threshold, you will undergo a finger stick at the end of
every three-minute stages (typically three in total). When a specific blood lactate is
reached, you will undergo 1 minute stages increasing 25 watts/minute until volitional
fatigue, or until you cannot turn the pedals anymore and choose to stop the test. Before
and after the exercise test you will complete the standard pulmonary function assessment
described above.
Your individual data will be completely confidential. No information will be revealed in
presentations or publications of the data that will reveal your identity.
We have asked your parents for their permission for you to do this study. Please talk this
over with them before you decide whether or not to participate by completing the
performance testing and all questionnaires.
If you have any questions at any time, please ask one of the researchers.
If you check "yes," it means that you have decided to participate and have read
everything that is on this form. You and your parents will be given a copy of this form to
keep.
______ Yes, I would like to participate in the study.
_______________________________________________
Signature of Subject

___________________
Date

_______________________________________________
Signature of Investigator

___________________
Date

If you have any questions or concerns, please contact Dr. Stephanie Kurti at
kurtisp@jmu.edu and (630) 205-6363, Dr. Mike Saunders at saundemj@jmu.edu at (540)
568-8121, Dr. Nicholas Luden at ludennd@jmu.edu and (540) 568-4069.
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Respiratory responses to exercise and prevalence of expiratory flow
limitation in adolescent endurance athletes and untrained controls.
Informed Consent (18 years of age and older)
IRB #18-0548
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Dr. Stephanie Kurti,
Dr. Mike Saunders, Dr. Nick Luden, and Katherine Smith from James Madison
University (JMU). The purpose of this study is to examine respiratory responses to
exercise in endurance trained adolescent cyclists and recreationally active, untrained
adolescent subjects. Additionally, to participate in the research, you must be healthy and
not diagnosed with any cardiovascular (i.e. heart murmur, aortic stenosis, unstable
angina, active endocarditis, acute myocarditis, hypertension), pulmonary (i.e. obstructive
or restrictive diseases), or metabolic diseases (i.e., type 1 and type 2 diabetes, insulin
resistance, hyper/hypothyroidism); or any other diseases in these categories that are
included in the American College of Sports Medicine guidelines.

Research Procedures
Should you decide to participate in this research study, you will be asked to sign this
consent form once all your questions have been answered to your satisfaction.
By participating in this study, the researchers will ask you to perform (1) a body
composition assessment, (2) a series of pulmonary function tests, (3) an exercise testing
protocol and (4) a series of questionnaires. Each step is outlined in detail below.
1) Body composition assessment:
When you first arrive to the laboratory, height, weight and body composition will be
assessed. A DEXA analysis will be performed for body composition assessment. For the
DEXA procedure, you will be asked to lie down on their back and remain still for
approximately 5-10 minutes until the scan is completed. All body composition
assessment will be performed according to the American College of Sports Medicine
guidelines.
2) Pulmonary Function Testing:
Following body composition assessment, you will be asked to undergo standard
pulmonary function testing according to the American Thoracic Society guidelines.
Duration for the tests are dependent on you effort how quickly you learn to adequately
perform the tests. Therefore, the duration of pulmonary function testing will be
approximately 20-30 minutes total. These tests include nitrogen washout to assess total
lung capacity (TLC). For this test, you will simply breathe into a mouthpiece attached to
the metabolic cart for ~7 minutes with a nose-clip on. After this, you will perform the
maximum flow-volume loop, where you will be asked to perform a maximal inhale
followed by a exhale where you will be asked to completely empty their lungs and hold it
for 6 seconds, followed by another maximum inhale. Next, you will be asked to perform
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a maximal exhale, maximal inhale and then be asked to hold your breath for
approximately 5 seconds, and then asked to perform another exhale. This test measures
the diffusion capacity of the lung. The next respiratory test will be a test in which you
will maximally exhale and inhale against a closed valve to measure maximum inspiratory
and expiratory pressures. Every pulmonary function test is non-invasive and only
involves various breathing maneuvers.
3) Exercise Testing:
You will then perform an incremental exercise test until volitional fatigue. The exercise
testing protocol will take approximately 15-20 minutes from start to complete. This test
simply requires you to start pedaling a bike at 50 watts (if recreationally active) or selfselected watts (if endurance trained in cycling) and increase the watts by 25 every 3
minutes until lactate threshold is reached. For lactate threshold, you will undergo a finger
stick at the end of every three-minute stages (typically three in total). When a specific
blood lactate is reached, you will undergo 1 minute stages increasing 25 watts/minute
until volitional fatigue, or until you cannot turn the pedals anymore and choose to stop
the test. Before and after the exercise test you will complete several of the standard
pulmonary function assessments described above.
Time Required
Participation in this study will require one session that will be approximately two hours in
duration, in which all testing can be completed.
Risks
The investigators do not perceive more than minimal risks from your involvement in this
study (that is, no risks beyond the risks associated with everyday life). Any potential
risks associated with the testing itself were outlined in the consent forms for performance
testing.
Additionally, the DEXA scan entails a low dose of radiation equivalent to approximately
one transatlantic flight (0.015 mSv= milliseievert). While there is no validated
questionnaire to define extensive exposure, radiation exposure is cumulative (200 DEXA
scans is equal to the cumulative exposure of living at sea level for a year (3 mSv)).
DEXA scans carry minimal X-ray exposure. To minimize exposure, the DEXA scan will
only be performed once.
Benefits
1) The exercise test to volitional fatigue is the best indicator of overall health. This is an
important and useful value for you to be aware of. Additionally, we will let you know
how you compared to individuals of the same age.
2) The data obtained from this project will be used to better understand the responses of
adolescent athletes to high-level endurance training. Therefore, athletes may be able to
use the data from this study to make well-informed decisions regarding your future
training.
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3) This research study will give physiologists, clinicians and sports practitioners more
information about lung function and limitations to exercise tolerance, which may lead to
improved advice for youth athletes.
Payment for participation
There is no payment for taking part in this study.
Confidentiality
The results of this research will be presented in classroom presentations, conferences and
research journals. You will be identified in the research records by a code name or
number. The researchers retain the right to use and publish non-identifiable data. When
the results of this research are published or discussed in conferences, no information will
be included that would reveal your identity. All data will be stored in a secure location
accessible only to the researchers. All information that matches up individual
respondents with their code number will be stored in a secure location separate from their
data.
There is one exception to confidentiality we need to make you aware of. In certain
research studies, it is our ethical responsibility to report situations of child abuse, child
neglect, or any life-threatening situation to appropriate authorities. However, we are not
seeking this type of information in our study nor will you be asked questions about these
issues.
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate.
Should you choose to participate, you can withdraw at any time without consequences of
any kind.
Questions about the Study
If you have questions or concerns during the time of your participation in this study, or
after its completion or you would like to receive a copy of the final aggregate results of
this study, please contact Dr. Stephanie Kurti at kurtisp@jmu.edu and (630) 205- 6363,
Dr. Mike Saunders at saundemj@jmu.edu and (540) 568-8121, Dr. Nicholas Luden at
ludennd@jmu.edu and (540) 568-4069.
For any questions about Your Rights as a Research Subject, please contact Dr. David
Cockley:
Chair, Institutional Review Board, James Madison University, (540) 568-2834,
cocklede@jmu.edu
Giving of Consent
I have read this consent form and I understand what is being requested of me as a
participant in this study. I freely consent to participate. I have been given satisfactory
answers to my questions. The investigator provided me with a copy of this form. I
certify that I am at least 18 years of age.
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______________________________________
Name of Participant (Signed)

______________
Date

______________________________________
Name of Researcher (Signed)

______________
Date

35

References
Aliverti, A. (2008). Lung and chest wall mechanics during exercise: Effects of expiratory
flow limitation. Respiratory Physiology & Neurobiology. 163: 90-99.
American Thoracic Society (1999). Dyspnea – Mechanisms, assessment, and
management: A consensus statement. Am J Respir Crit Care Med. 159: 321-340.
Babb, T.G. (2013). Exercise ventilatory limitation: The role of expiratory flow limitation.
Exerc. Sport Sci. Rev. 41(1): 11-18.
Babcock, M.A., Johnson, B.D., Pegelow, D.F., Suman, O.E., Griffin, D., & Dempsey,
J.A. (1995). Hypoxic effects on exercise-induced diaphragmatic fatigue in normal
healthy humans. J Appl Physiol. 78(1): 82-92.
Beck, K.C., Offord, K.P., & Scanlon, P.D. (1994). Bronchoconstriction occurring during
exercise in asthmatic subjects. Am J Respir Crit Care Med. 149(2 Pt 1): 352-357.
Calligaro, G.L., Raine, R.I., Bateman, M.E., Bateman, E.D., & Cooper, C.B. (2014).
Comparing dynamic hyperinflation and associated dyspnea induced by
metronome-paced tachypnea versus incremental exercise. COPD: Journal of
Chronic Obstructive Pulmonary Disease. 11(1): 105-112.
Chenoweth, L.M., Smith, J.R., Ferguson, C.S., Downey, A.E., & Harms, C.A. (2015).
The effects of antioxidant vitamin supplementation on expiratory flow rates at rest
and during exercise. Eur J Appl Physiol. 115(10): 2049-2058.
Dempsey, J.A., Hanson, P.G., & Henderson, K.S (1984). Exercise-induced arterial
hypoxemia in healthy human subjects at sea level. J. Phyiol. 355: 161-175.

36

Dempsey, J.A. & Smith, C.A. (2014). Pathophysiology of human ventilatory control.
Eur. Respir. J. 44: 495-512.
Derchak, P.A., Stager, J.M., Tanner, D.A., & Chapman, R.F. (2000). Expiratory flow
limitation confounds ventilatory response during exercise in athletes. Med Sci
Sports Exerc. 32(11): 1873-1879.
Duke, J.W., Stickford, J.L., Weavil, J.C., Chapman, R.F., Stager, J.M., & Mickleborough,
T.D. (2014). Operating lung volumes are affected by exercise mode but not trunk
and hip angle during maximal exercise. Eur J Appl Physiol. 114(11): 2387-2397.
Emerson, S.R., Kurti, S.P., Rosenkranz, S.K., Smith, J.R., & Harms, C.A. (2015).
Decreased prevalence of exercise expiratory flow limitation from pre- to
postpuberty. Med Sci Sports Exerc. 47(7): 1503-1511.
Guenette, J.A., Webb, K.A., & O’Donnell, D.E. (2012). Does dynamic hyperinflation
contribute to dyspnoea during exercise in patients with COPD? European
Respiratory Journal. 40: 322-329.
Harms, C.A. (2000). Effect of skeletal muscle demand on cardiovascular function. Med
Sci Sports Exerc. 32(1): 94-99.
Harms, C.A. & Rosenkranz, S. (2008). Sex differences in pulmonary function during
exercise. Med. Sci. Sports Exerc. 40(4): 664-668.
Helenius, I.J. & Haahtela, T. (2000). Allergy and asthma in elite summer sport athletes. J
Allergy Clin Immunol. 106(3): 444-452.

37

Helenius, I.J., Tikkanen, H.O., Sarna, S., & Haahtela, T. (1998). Asthma and increased
bronchial responsiveness in elite athletes: Atopy and sport event as risk factors. J
Allergy Clin Immunol. 101(5): 646-652.
Iandelli, I., Aliverti, A., Kayser, B., Dellaca, R., Cala, S.J., Duranti, R., Kelly, S., Scano,
G., et al (2002). Determinants of exercise performance in normal men with
externally imposed expiratory flow limitation. J Appl Physiol. 92: 1943-1952.
Johnson, B.D., Saupe, K.W., & Dempsey, J.A. (1992). Mechanical constraints on
exercise hyperpnea in endurance athletes. J. Appl. Physiol. 73(3): 874-886.
Johnson, B.D., Weisman, I.M., Zeballos, R.J., & Beck, K.C. (1999). Emerging concepts
in the evaluation of ventilatory limitation during exercise: the exercise tidal flowvolume loop. Chest. 116(2): 488-503.
Kippelen, P., Caillaud, C., Coste, O., Godard, P., & Prefaut, C. (2004). Asthma and
exercise-induced bronchoconstriction in amateur endurance-trained athletes. Int J
Sports Med. 25: 130-132.
Knudson, R.J., Schroter, R.C., Knudson, D.W., & Sugihara, S. (1983). Influence of
airway geometry on expiratory flow limitation and density dependence.
Respiration Physiology. 52: 113-123.
Marcus, C.L., Fernandes Do Prado, L.B., Lutz, J., Katz, E.S., Black, C.A., & Carson,
K.A. (2004). Developmental changes in upper airway dynamics. J Appl Physiol.
97: 98-108.

38

McClaran, S.R., Harms, C.A., Pegelow, D.F., & Dempsey, J.A. (1998). Smaller lungs in
women affect exercise hyperpnea. J Appl Physiol. 84(6): 1872-1881.
McFadden, E.R. Jr., Pichurko, B.M., Bowman, H.F., Ingenito, E., Burns, S., Dowling, N.,
& Solway, J. (1986) Postexertional airway rewarming and thermally induced
asthma. J Clin Invest. 78: 18-25.
McKenzie, D.C. (2012). Respiratory physiology: adaptations to high-level exercise. Br J
Sports Med. 46: 381-384.
Mead, J. (1980). Expiratory flow limitation: a physiologist’s point of view. Fed Proc.
39(10): 2771-2775.
Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R.
et al. (2005). Standardisation of spirometry. Eur Resp J. 26: 319-338.
Mohammadizadeh, M.A., Ghanbarzadeh, M., Habibi, A., Shakeryan, S., & Nikbakht, M.
(2013) The effect of high intensity interval training in high/low temperatures on
exercise-induced bronchoconstriction (EIB) in trained adolescent males. Tanaffos.
12(3): 29-43.
Mota, S., Casan, P., Drobnic, F., Giner, J., Ruiz., Sanchis, J., & Milic-Emili, J. (1999).
Expiratory flow limitation during exercise in competition cyclists. J. Appl.
Physiol. 86(2): 611-616.
Nourry, C., Deruelle, F., Fabre, C., Baquet, G., Bart, F., Grosbois, J-M., Berthoin, S., et
al. (2005). Exercise flow-volume loops in prepubescent aerobically trained
children. J Appl Physiol. 99: 1912-1921.

39

Pellegrino, R., Brusasco, V., Rodarte, J.R., & Babb, T.G. (1993). Expiratory flow
limitation and regulation of end-expiratory lung volume during exercise. J Appl
Physiol. 74(5): 2552-2558.
Pianosi, P.T. & Smith, J.R. (2019). Ventilatory limitation of exercise in pediatric subjects
evaluated for exertional dyspnea. Front. Physiol. 10:20.
Pinto-Plata, V.M., Celli-Cruz, R.A., Vassaux, C., Torre-Bouscoulet, L., Mendes, A.,
Rassulo, J., & Bartolome, B.R. (2007). Differences in cardiopulmonary exercise
test results by American Thoracic Society/European Respiratory Society-Global
initiative for chronic obstructive lung disease stage categories and gender.
CHEST. 132: 1204-1211.
Robben, K.A., Poole, D.C., & Harms, C.A. (2013). Maximal oxygen uptake validation in
children with expiratory flow limitation. Pediatric Exercise Science. 25: 84-100.
Rundell, K.W. & Jenkinson, D.M. (2002). Exercise-induced bronchospasm in the elite
athlete. 32(9): 583-600.
Sheel, A.W., Dominelli, P.B., & Molgat-Seon, Y. (2016). Revisiting dysanapsis: sexbased differences in airways and the mechanics of breathing during exercise. Exp
Physiol. 101(2): 213-218.
Sheel, A.W. & Guenette, J.A. (2008). Mechanics of breathing during exercise in men and
women: sex versus body size differences? Exerc. Sport Sci. Rev. 36(3): 128-134.
Smith, J.R., Ade, C.J., Broxterman, R.M., Skutnik, B.C., Barstow, T.J., Wong, B.J., &
Harms, C.A. (2014). Influence of exercise intensity on respiratory muscle fatigue

40

and brachial artery blood flow during cycling exercise. Eur J Appl Physiol. 114:
1767-1777.
Smith, J.R., Cross, T.J., Van Iterson, E.H., Johnson, B.D., & Olson, T.P. (1985).
Resistive and elastic work of breathing in older and younger adults during
exercise. J Appl Physiology. 125(1): 190-197.
Smith, J.R., Emerson, S.R., Kurti, S.P., Gandhi, K., & Harms, C.A. (2015). Lung volume
and expiratory flow rates from pre- to post-puberty. Eur J Appl Physiol.
115:1645-1652.
Smith, J.R., Kurti, S.P., Meskimen, K., & Harms, C.A. (2017). Expiratory flow limitation
and operating lung volumes during exercise in older and younger adults.
Respiratory Physiology & Neurobiology. 240: 26-31.
Stickland, M.K., Butcher, S.J., Marciniuk, D.D., & Bhutani, M. (2012). Assessing
exercise limitation using cardiopulmonary exercise testing. Pulmonary Medicine.
2012: 1-13.
Swain, K.E., Rosenkranz S.K., Beckman, B., & Harms, C.A. (2010). Expiratory flow
limitation during exercise in prepubescent boys and girls: prevalence and
implications. J Appl Physiol. 108: 1267-1274.
Tecklenburg-Lund, S., Turner, L.A., Chapman, R.F., Stager, J.M., & Mickleborough,
T.D. (2011). Expiratory flow limitation and ventilatory responses to inspiratory
loading and maximal exercise in trained cyclists. Med Sci Sports Ex. 43(5): 632633.

41

Turner, J.M., Mead, J., & Wohl, M.E. (1968). Elasticity of human lungs in relation to
age. J Appl Physiol. 25(6): 664-671.
Vilozni, D., Lavie, M., Ofek, M., Sarouk, I., Bar-Aluma, B-E., Dagan, A., Ashkenazi, M,
et al. (2016). Consequences of expiratory flow limitation at rest in subjects with
cystic fibrosis. Ann Am Thorac Soc. 13(6): 825-832.
Vogiatzis, I., Zakynthinos, S., Georgiadou, O., Golemati, S., Pedotti, A., Macklem, P.T.,
Roussos, C., et al. (2007). Oxygen kinetics and debt during recovery from
expiratory flow-limited exercise in healthy humans. Eur J Appl Physiol. 99:265274.
Walls, J., Maskrey, M., Wood-Baker, R., & Stedman, W. (2002). Exercise-induced
oxyhaemoglobin desaturation, ventilatory limitation and lung diffusing capacity
in women during and after exercise. Eur J Appl Physiol. 87(2): 145-152.
Weavil, J.C., Duke, J.W., Stickford, J.L., Stager, J.M., Chapman, R.F., & Mickleborough,
T.D. (2015). Endurance exercise performance in acute hypoxia is influenced by
expiratory flow limitation. Eur J Appl Physiol. 115: 1653-1663.
Wetter, T.J., Harms, C.A., Nelson, W.B., Pegelow, D.F., & Dempsey, J.A. (1999).
Influence of respiratory muscle work on VO2 and leg blood flow during
submaximal exercise. J Appl Physiol. 87(2): 643-651.

